Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1231-1240 of 2905 for cancer

Edit search filters
  1. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, And Rucaparib In Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, Or Biliary Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study To Investigate The Effects Of GC4419 On Radiation-Induced Oral Mucositis In Patients With Head/Neck Cancer

    Jacksonville, FL

  3. A Study To Evaluate Lasofoxifene Versus Fulvestrant In Advanced Or Metastatic ER+/HER2− Breast Cancer Patients With An ESR1 Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study of Aplidin for Treating Patients with Primary Myelofibrosis, Post Polycythemia Vera or Essential Thrombocythemia Myelofibrosis

    Rochester, MN

  5. Electron Beam Intraoperative Radiation Therapy Following Chemoradiation In Patients With Pancreatic Cancer With Vascular Involvement (PACER)

    Jacksonville, FL, Rochester, MN

  6. Pemigatinib To Treat Metastatic Or Unresectable Colorectal Cancer Harboring FGFR Alterations

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. A Study To See If Genetic Risk Estimation Of Breast Cancer Influences The Use Of Preventive Medication

    Rochester, MN

  8. Proton Beam Or Intensity-Modulated Radiation Therapy In Preserving Brain Function In Patients With IDH Mutant Grade II Or III Glioma

    Rochester, MN

  9. Claudin18.2 CAR-T (CT041) In Patients With Gastric, Pancreatic Cancer, Or Other Specified Digestive Cancers

    Rochester, MN

  10. Tai Chi To Optimize Transplant Outcomes For Multiple Myeloma

    Jacksonville, FL

.

Mayo Clinic Footer